TABLE 4.
Severe-malaria Criteriaa | No. of patients (n = 248) | Cytokine level (geometric mean pg/ml)c
|
|||||
---|---|---|---|---|---|---|---|
IL-1β | IL-6 | IL-8 | IL-10 | IL-12(p70) | TNF-α | ||
Cerebral | 100 | 17.6 | 754.5 | 109.5 | 1,405.6 | 66.1 | 10.5 |
Noncerebral | 130b | 14.4 | 311.4 | 102 | 868.8 | 43.6 | 9.5 |
P | NSc | <0.001 | NS | 0.006 | NS | NS | |
Severe anemia | 17b | 14.7 | 199.2 | 84.7 | 391.1 | 26.7 | 9.7 |
Hemoglobin at >5 g/dl | 213 | 17.2 | 487.6 | 106.2 | 1,160.9 | 55.2 | 9.9 |
P | NS | 0.03 | NS | 0.002 | NS | NS | |
Cerebral/anemia | 18 | 18.8 | 797.5 | 116.2 | 1,430.8 | 55.6 | 10.9 |
Neither | 213 | 14.4 | 311.4 | 102 | 868.8 | 43.6 | 9.5 |
P | NS | <0.001 | NS | 0.003 | NS | NS | |
Hyperparasitemia | 92 | 15.4 | 336.6 | 116.9 | 1,007.3 | 50.8 | 9.7 |
<500,000/mm3 | 156 | 16.1 | 602.1 | 103.8 | 1,157.5 | 47.8 | 10.4 |
P | NS | 0.002 | NS | NS | NS | NS |
Significance levels were calculated by Mann-Whitney rank sum analysis.
Patients with concomitant cerebral malaria and severe anemia were eliminated from analysis.
NS, not significant.